SOCS-3 antagonises the proliferative and migratory effects of fibroblast growth factor-2 in prostate cancer by inhibition of p44/p42 MAPK signalling.
Puhr
Martin
M
Department of Urology, Innsbruck Medical University, Anichstrasse 35, A-6020 Innsbruck, Austria.
Santer
Frédéric R
FR
Neuwirt
Hannes
H
Marcias
Gemma
G
Hobisch
Alfred
A
Culig
Zoran
Z